Aureus Sciences Cited In Papers
Prior to 2011, Aureus Sciences is mentioned as Aureus Pharma.
Download this table as a PDFYear | Authors | Affiliation | Title | Reference | Cited/Used |
2010 | Francisco-Javier Gamo, Laura M. Sanz, Jaume Vidal et al. | Tres Cantos Medicines Development Campus, GlaxoSmithKline | Thousands of chemical starting points for antimalarial lead identification | Nature | AurSCOPE databases |
2010 | Nicolas Renault, Arnaud Gohier, Philippe Chavatte, Amaury Farce | Faculté des Sciences Pharmaceutiques et Biologiques, Laboratoire de Chimie Thérapeutique, Université Nord de France | Novel structural insights for drug design of selective 5-HT2C inverse agonists from a ligand-biased receptor model | J. Med. Chem. 2010, 45, 5086–5099 | AurSCOPE databases |
2009 | Ralf Heilker, Michael Wolff, Christofer S. Tautermann and Michael Bieler | Department of Lead Discovery, Boehringer Ingelheim Pharma | G-protein-coupled receptor-focused drug discovery using a target class platform approach | Drug Discovery Today Vol 14(5/6), p. 231, 2009. | AurSCOPE GPCR |
2009 | J. Burton, E. Danloy, and D.P. Vercauteren | Laboratoire de Physico-Chimie Informatique University of Namur, Belgium | Fragment-based prediction of cytochromes P450 2D6 and 1A2 inhibition by recursive partitioning | SAR and QSAR in Environmental Research Vol. 20, Nos. 3-4, April-June 2009, 185-205 | AurSCOPE ADME |
2009 | Thomas Klabunde, Clemens Giegerich, and Andreas Evers | Research & DeVelopment, Drug Design, Sanofi-Aventis, Frankfurt, Germany | Sequence-Derived Three-Dimensional Pharmacophore Models for G-Protein-Coupled Receptors and Their Application in Virtual Screening | J. Med. Chem. 2009, 52, 2923–2932 | AurSCOPE GPCR |
2009 | Britta Nisius, Andreas H. Göller and Jürgen Bajorath | Department of Life Science Informatics, B-IT, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany Bayer HeathCare AG, Global Drug Discovery, Lead Generation and Optimization, Wuppertal, Germany | Combining Cluster Analysis, Feature Selection and Multiple Support Vector Machine Models for the Identification of Human Ether-a-go-go Related Gene Channel Blocking Compounds | Chem Biol Drug Des 2009; 73: 17–25 | AurSCOPE hERG |
2009 | Dora M. Schnur, Mark A. Hermsmeier, and Andrew J. Tebben | Computer Aided Drug Design and Lead Discovery, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, NJ, USA | Are Target-Family-Privileged Substructures Truly Privileged? | J. Med. Chem. 2006, 49, 2000-2009 | AurSCOPE GPCR |
2009 | Benny Kneissl, Bettina Leonhardt, Andreas Hildebrandt, and Christofer S. Tautermann | Boehringer-Ingelheim Pharma GmbH & Co. Biberach, Germany | Revisiting Automated G-Protein Coupled Receptor Modeling: The Benefit of Additional Template Structures for a Neurokinin-1 Receptor Model | J. Med. Chem. 2009, 52, 3166–3173 | AurSCOPE GPCR |
2008 | Thomas Klabunde | Sanofi-Aventis Deutschland, | Chapter 6 - GPCR Antitarget Modeling: Pharmacophore Models to Avoid GPCR-Mediated Side Effects | Book :Antitargets: Prediction and Prevention of Drug Side Effects | AurSCOPE GPCR |
2008 | Khac-Minh Thai and Gerhard F. Ecker | Department of Medicinal Chemistry, University of Vienna | A binary QSAR model for classification of hERG potassium channel blockers | Bioorganic & Medicinal Chemistry 16 (2008) 4107–4119 | AurSCOPE hERG |
2008 | Paul Bamborough, David Drewry, Gavin Harper, Gary K. Smith, and Klaus Schneider | Molecular Discovery Research, GlaxoSmithKline | Assessment of Chemical Coverage of Kinome Space and Its Implications for Kinase Drug Discovery | J. Med. Chem. 2008, 51, 7898–7914 | AurSCOPE Kinase |
2008 | Petra Ross-Macdonald, Heshani de Silva, Qi Guo, Hong Xiao, Chen-Yi Hung, Becky Penhallow, Jay Markwalder, Liqi He, Ricardo M. Attar, Tai-an Lin, Steven Seitz, Charles Tilford, Judith Wardwell-Swanson, and Donald Jackson | Bristol-Myers Squibb Research and Development, Princeton, New Jersey, USA | Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors | Mol Cancer Ther 2008;7(11), 3490-3498 | AurSCOPE Kinase |
2008 | Stefan Senger and Andrew R. Leach | Medicines Research Centre, GlaxoSmithKline Research & Development, Stevenage, UK | SAR Knowledge Bases in Drug Discovery | Annual Reports in Computational Chemistry Vol. 4, 2008, p. 203-216 | AurSCOPE databases |
2007 | Max K. Leong | Department of Chemistry National Dong Hwa UniVersity, Taiwan | A Novel Approach Using Pharmacophore Ensemble/Support Vector Machine (PhE/SVM) for Prediction of hERG Liability | Chem. Res. Toxicol. 2007, 20, 217-226 | AurSCOPE hERG |
2007 | S. Ekins, J. Mestres and B. Testa | Department of Pharmaceutical Sciences, University of Maryland, USA Institut Municipal d’Investigacio´ Me`dica and Universitat Pompeu Fabra, Barcelona, Spain University Hospital Centre, Lausanne, Switzerland | In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling | British Journal of Pharmacology (2007) 152, 9–20 | AurSCOPE databases |
2007 | Kristina Hettne, Montserrat Cases, Scott Boyer and Jordi Mestres | Safety Assessment, AstraZeneca R&D, 43183 Mölndal, Sweden Institut Municipal d’Investigacio´ Me`dica and Universitat Pompeu Fabra, Barcelona, Spain | Connecting Small Molecules to Nuclear Receptor Pathways | Current Topics in Medicinal Chemistry 2007, 7, 1530-1536 | AurSCOPE databases |
2006 | Yann Bidault | Micropolis, Isatis, Gap, France | A flexible approach for optimizing in silico ADME/Tox characterization of lead candidates | Expert Opin. Drug Metab. Toxicol. 2006, Vol 2(1) p 157-168. | AurSCOPE ADME |
2006 | Tudor I. Oprea, Alexander Tropsha | Division of Biocomputing, University of New Mexico, NM, USA Laboratory for Molecular Modeling, School of Pharmacy, NC, USA | Target, chemical and bioactivity databases – integration is key | Drug Discovery Today: Technologies 2006, Vol 3, p. 357-365 | AurSCOPE databases |
2006 | Edgar Jacoby, Rochdi Bouhelal, Marc Gerspacher, Klaus Seuwen | Novartis Institutes for Biomedical Research Basel, Switzerland | The 7 TM G-Protein-Coupled Receptor Target Family | ChemMedChem 2006, 1, 760–782 | AurSCOPE GPCR |
2005 | Martin Stahl, Harald Mauser, Mark Tsui, and Neil R. Taylor | F. Hoffmann-La Roche Ltd. Basel, Switzerland | A Robust Clustering Method for Chemical Structures | J. Med. Chem. 2005, 48, 4358-4366 | AurSCOPE GPCR |
2005 | Andreas Evers, Gerhard Hessler, Hans Matter, and Thomas Klabunde | Sanofi-Aventis, Chemical Sciences, Drug Design, Frankfur , Germany | Virtual Screening of Biogenic Amine-Binding G-Protein Coupled Receptors: Comparative Evaluation of Protein- and Ligand-Based Virtual Screening Protocols | J. Med. Chem. 2005, 48, 5448-5465 | AurSCOPE GPCR |
2004 | Patrick Jimonet and Robert Jäger | Aventis Pharmaceuticals (sanofi-aventis) | Strategies for designing GPCR-focused libraries and screening sets | Curr Opin Drug Discov Devel. 2004 May;7(3):325-33. | AurSCOPE GPCR |